PATH Stock Slips As RBC Slashes UiPath Price Target

UiPath Inc. stocks have been trading down by -3.68 percent amid bearish sentiment over slowing automation software demand.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading PATH

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

RBC Capital cut UiPath’s PATH price target from $14 to $12, keeping a Sector Perform rating.
The firm flagged execution risk, weak job posting trends, and the need for clearer AI payoffs ahead of Q1 results.
Wall Street’s consensus on PATH remains hold, with an average target around $13.67, signaling cautious, wait-and-see trading sentiment.

Live Update At 16:02:03 EDT: On Friday, June 05, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -3.68%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

UiPath’s PATH chart tells a clear story. Over the past few weeks, PATH has bounced from roughly $9.50 to above $13.00, then slipped back toward the low $11s. That’s a strong rally followed by cooling momentum. The latest close near $11.24 shows traders backing away after that spike to $13.10 on 2026/06/01.

Intraday, PATH traded in a tight band around $11.20–$11.30, with early selling from the $11.70 premarket area and then a slow grind sideways. That kind of narrow range after a multi-day pullback often signals indecision. Bulls and bears are squaring off, but neither is in full control.

More Breaking News

Fundamentally, UiPath just posted quarterly revenue of about $418.4M with gross margin above 80%, and PATH printed a modest net profit near $22.5M. That’s a big shift from the heavy losses many traders remember. Free cash flow of roughly $129M and a cash pile north of $600M give PATH real staying power, while debt remains low. Still, a price-to-sales ratio around 4 and a P/E in the mid-20s mean traders are paying for growth and execution. When an execution story like PATH stumbles, the market doesn’t forgive quickly.

Why Traders Are Watching PATH After RBC’s Cut

RBC Capital’s latest move on UiPath put PATH right back on active traders’ screens. The firm cut its PATH price target from $14 to $12 and kept a Sector Perform rating. That’s not a screaming downgrade, but it is a clear vote of caution. When an established shop like RBC says, “Show me several quarters of consistent execution,” momentum traders listen.

The message is simple: PATH needs to prove it can turn all the AI and automation hype into durable revenue and profit. RBC pointed to non-seed pricing needing work and called out the lack of clear, measurable AI-driven benefits so far. Add in RBC’s concern over negative job posting trends, and you’re looking at a demand picture that might be softening just as everyone is chasing AI names.

At the same time, the broader Street still sits at a hold on PATH with a mean target around $13.67. That puts the consensus only modestly above where PATH trades now. For short-term traders, that means the easy upside from “undervalued” narratives is thin. PATH is in a prove-it zone.

On the chart, PATH has already pulled back from $13.10 to the low $11s, right as this cautious analyst tone hits. If PATH fails to hold the $11 area, traders will eye the prior support cluster between $10 and $10.50. If, instead, PATH bases here and pushes back through $12 on volume, it could set up a bounce toward that $13–$14 analyst target band. Either way, UiPath remains a battleground name where execution headlines will move the tape.

Conclusion

For active traders, PATH is now a classic “show me” stock. UiPath has strong gross margins, improving profitability, solid free cash flow, and plenty of cash. The balance sheet looks clean, and the business has real scale. But PATH also carries premium growth pricing, and RBC’s price-target cut to $12 signals that the Street is no longer giving UiPath a free pass on execution.

RBC highlighted what many chart-focused traders already sensed in the recent pullback: the bar is higher now. PATH must demonstrate stable demand, better pricing on non-seed deals, and tangible AI-driven wins to reignite a strong trend. Until that happens, hold-level ratings and a consensus target near $13.67 keep expectations muted.

For traders, that sets up a simple framework. Respect the levels, respect the news, and avoid marrying the story. As Tim Sykes likes to say, “The market doesn’t care about your opinion, it cares about price action — adapt or get left behind.” That mindset pairs well with a disciplined, rule-based approach to trading PATH. As Tim Bohen, lead trainer with StocksToTrade says, “The best trades are the ones you can make without emotion. Plan it, then execute it as if it’s routine.” With PATH, that means watching how the stock reacts to every new data point and being ready to cut losses fast if the execution story slips further. This is educational and research material, not a trade alert — the real edge comes from doing the work and letting the chart confirm the story.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!